Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Magnani

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Cancer Research|September 1, 1986
Glycolipid antigen expression in human lung cancerS L Spitalnik, P F Spitalnik, C Dubois, et al.
Blood Cancer Journal|August 22, 2019
Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapyBarbara Muz, Feda Azab, Mark Fiala, et al.
Reumatismo|July 22, 2011
[Disease activity assessment in large vessel vasculitis]L Magnani, A Versari, D Salvo, et al.
Plos One|July 3, 2014
Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemiaTed Wun, Lori Styles, Laura DeCastro, et al.
Thrombosis and Haemostasis|March 17, 2017
E-selectin inhibition with GMI-1271 decreases venous thrombosis without profoundly affecting tail vein bleeding in a mouse modelDorian L Culmer, Misha L Dunbar, Angela E Hawley, et al.
Haematologica|September 8, 1999
Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosisF Locatelli, C Perotti, L Torretta, et al.
Blood Reviews|March 16, 2024
Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?Geoffrey L Uy, Daniel J DeAngelo, Jay N Lozier, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Rational targets for the early detection of lung cancerJ L Mulshine, R I Linnoila, S M Jensen, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 4, 2012
Pre-organization of the core structure of E-selectin antagonistsDaniel Schwizer, John T Patton, Brian Cutting, et al.
Blood|March 4, 2015
Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid useMarilyn J Telen, Ted Wun, Timothy L McCavit, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Cancer Research|September 1, 1986
Glycolipid antigen expression in human lung cancerS L Spitalnik, P F Spitalnik, C Dubois, et al.
Blood Cancer Journal|August 22, 2019
Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapyBarbara Muz, Feda Azab, Mark Fiala, et al.
Reumatismo|July 22, 2011
[Disease activity assessment in large vessel vasculitis]L Magnani, A Versari, D Salvo, et al.
Plos One|July 3, 2014
Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemiaTed Wun, Lori Styles, Laura DeCastro, et al.
Thrombosis and Haemostasis|March 17, 2017
E-selectin inhibition with GMI-1271 decreases venous thrombosis without profoundly affecting tail vein bleeding in a mouse modelDorian L Culmer, Misha L Dunbar, Angela E Hawley, et al.
Haematologica|September 8, 1999
Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosisF Locatelli, C Perotti, L Torretta, et al.
Blood Reviews|March 16, 2024
Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?Geoffrey L Uy, Daniel J DeAngelo, Jay N Lozier, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Rational targets for the early detection of lung cancerJ L Mulshine, R I Linnoila, S M Jensen, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 4, 2012
Pre-organization of the core structure of E-selectin antagonistsDaniel Schwizer, John T Patton, Brian Cutting, et al.
Blood|March 4, 2015
Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid useMarilyn J Telen, Ted Wun, Timothy L McCavit, et al.
Pageof 12